デフォルト表紙
市場調査レポート
商品コード
640960

ヒト化マウスモデルの世界市場

Global Market Study on Humanized Mice Model: Biotechnology Companies to Gear Up in Terms of Adoption; Research and Development Emerging at Rapid Pace as the Need of the Hour

出版日: | 発行: Persistence Market Research | ページ情報: 英文 157 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.57円
ヒト化マウスモデルの世界市場
出版日: 2018年04月12日
発行: Persistence Market Research
ページ情報: 英文 157 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートではヒト化マウスモデルの世界市場を取り上げ、市場成長促進要因や阻害要因、市場動向、また市場競争状況に関する広範な調査を通じて市場の現状分析ならびに将来予測を行っています。さらに市場をモデルタイプ別、用途別、エンドユーザ別、および地域/国別に分類し、それぞれ詳細な分析と予測とを提供しています。

第1章 ヒト化マウスモデルの世界市場 - エグゼクティブ・サマリー

第2章 調査手法

第3章 前提条件および使用略語

第4章 ヒト化マウスモデルの世界市場概要

  • 序論
  • ヒト化マウスモデルの世界市場のダイナミクス
  • 市場成長促進要因および阻害要因:影響度分析
  • ヒト化マウスモデルの世界市場規模および将来予測

第5章 ヒト化マウスモデルの世界市場のモデルタイプ別分析および将来予測

  • 序論
  • モデルタイプ別市場規模予測
  • モデルタイプ別市場魅力度分析

第6章 ヒト化マウスモデルの世界市場の用途別分析および将来予測

  • 序論
  • 用途別市場規模予測
  • 用途別市場魅力度分析

第7章 ヒト化マウスモデルの世界市場のエンドユーザ別分析および将来予測

  • 序論
  • エンドユーザ別市場規模および将来予測
  • エンドユーザ別市場魅力度分析

第8章 ヒト化マウスモデルの世界市場の地域別分析および将来予測

  • 序論
  • 地域別市場規模および将来予測
  • 地域別市場魅力度分析

第9章 北米のヒト化マウスモデル市場分析および将来予測

  • 序論
  • 国別市場規模予測
  • モデルタイプ別市場規模予測
  • 用途別市場規模予測
  • エンドユーザ別市場規模予測
  • 市場魅力度分析

第10章 ラテンアメリカのヒト化マウスモデル市場分析および将来予測

第11章 欧州のヒト化マウスモデル市場分析および将来予測

第12章 アジア太平洋地域のヒト化マウスモデル市場分析および将来予測

第13章 中東・アフリカ地域のヒト化マウスモデル市場分析および将来予測

第14章 市場競争状況 (収益額、商品、特記事項)

  • THE JACKSON LABORATORY
  • Taconic Biosciences, Inc.
  • Genoway S.A.
  • Yecuris Corporation
  • Charles River Laboratories, Inc.
  • Crown Bioscience Inc.
  • Ingenious Targeting Laboratory Inc.
  • Horizon Discovery Group plc
  • HuMurine Technologies
  • Trans Genic Inc., Ltd.
図表

List of Table

  • Table 01: Global Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 2013-2026
  • Table 02: Global Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 2013-2026
  • Table 03: Global Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 2013-2026
  • Table 04: Global Humanized Mice Model Market Size (US$ Mn) Forecast, by Region, 2013-2026
  • Table 05: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Country, 2013-2026
  • Table 06: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 2013-2026
  • Table 07: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 2013-2026
  • Table 08: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 2013-2026
  • Table 09: Latin America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Country, 2013-2026
  • Table 10: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 2013-2026
  • Table 11: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 2013-2026
  • Table 12: Latin America Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 2013-2026
  • Table 13: Europe Humanized Mice Model Market Size (US$ Mn) and Forecast, by Country, 2013-2026
  • Table 14: Europe Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 2013-2026
  • Table 15: Europe Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 2013-2026
  • Table 16: Europe Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 2013-2026
  • Table 17: Asia Pacific Humanized Mice Model Market Size (US$ Mn) and Forecast, by Country, 2013-2026
  • Table 18: Asia Pacific Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 2013-2026
  • Table 19: Asia Pacific Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 2013-2026
  • Table 20: Asia Pacific Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 2013-2026
  • Table 21: MEA Humanized Mice Model Market Size (US$ Mn) and Forecast, by Country, 2013-2026
  • Table 22: MEA Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 2013-2026
  • Table 23: MEA Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 2013-2026
  • Table 24: MEA Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 2013-202

List of Figure

  • Figure 01: Global Humanized Mice Model Market Split By Model Type (2016A)
  • Figure 02: Global Humanized Mice Model Market Split By Application (2016A)
  • Figure 03: Global Humanized Mice Model Market Split By End User (2016A)
  • Figure 04: Global Humanized Mice Model Market Split By Region (2016A)
  • Figure 05: Global Humanized Mice Model Market Size (US$ Mn) Forecast and Y-o-Y Growth Rate (%), 2013-2026
  • Figure 06: Global Humanized Mice Model Market Absolute $ Opportunity, 2016-2026
  • Figure 07: Global Humanized Mice Model Market BPS Analysis, by Model Type, 2017 & 2025
  • Figure 08: Global Humanized Mice Model Y-o-Y Growth Rate (%), By Model Type, 2016-2026
  • Figure 09: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Genetic Humanized Mice Model
  • Figure 10: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell-Based Humanized Mice Model
  • Figure 11: Global Humanized Mice Model Market Attractiveness Analysis, by Model Type, 2017-2026
  • Figure 12: Global Humanized Mice Model Market BPS Analysis, by Application, 2017 & 2025
  • Figure 13: Global Humanized Mice Model Y-o-Y Growth Rate (%), By Application, 2016-2026
  • Figure 14: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Toxicology segment
  • Figure 15: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Oncology segment
  • Figure 16: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Infectious Disease segment
  • Figure 17: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by GvHD segment
  • Figure 18: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Regenerative Medicine segment
  • Figure 19: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Neurobiology segment
  • Figure 20: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by other applications segment
  • Figure 21: Global Humanized Mice Model Market Attractiveness Analysis, by Application, 2017-2026
  • Figure 22: Global Humanized Mice Model Market BPS Analysis, By End User, 2017 & 2025
  • Figure 23: Global Humanized Mice Model Y-o-Y Growth Rate (%), By End User, 2016-2026
  • Figure 24: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Biotechnology Companies 2015-2025
  • Figure 25: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Contract Research Organizations 2013-2026
  • Figure 26: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic & Research Institutes, 2013-2026
  • Figure 27: Global Humanized Mice Model Market Attractiveness Analysis, by End User, 2017-2026
  • Figure 28: Global Humanized Mice Model Market BPS Analysis, by Region, 2017 & 2025
  • Figure 29: Global Humanized Mice Model Y-o-Y Growth Rate (%), by Region, 2016-2026
  • Figure 30: North America Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 31: Latin America Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 32: Europe Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 33: Asia-Pacific Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 34: Middle East & Africa Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
  • Figure 35: Global Humanized Mice Model Market Attractiveness Analysis, by Region, 2017-2026
  • Figure 36: North America Humanized Mice Model Market BPS Analysis, by Country, 2017 & 2025
  • Figure 37: North America Humanized Mice Model Y-o-Y Growth Rate (%), by Country, 2016-2026
  • Figure 38: U.S. Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 39: Canada Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
  • Figure 40: North America Humanized Mice Model Market Analysis by Model Type, 2017-2026
  • Figure 41: North America Humanized Mice Model Market Analysis by Application, 2017-2026
  • Figure 42: North America Humanized Mice Model Market Analysis by End Users, 2017-2026
  • Figure 43: North America Humanized Mice Model Market Analysis by Country, 2017-2026
  • Figure 44: Latin America Humanized Mice Model Market BPS Analysis, by Country, 2017 & 2025
  • Figure 45: Latin America Humanized Mice Model Y-o-Y Growth Rate (%), by Country, 2016-2026
  • Figure 46: Brazil Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 47: Mexico Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
  • Figure 48: Rest of Latin America Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 49: Latin America Humanized Mice Model Market Analysis by Model Type, 2017-2026
  • Figure 50: Latin America Humanized Mice Model Market Analysis by Application, 2017-2026
  • Figure 51: Latin America Humanized Mice Model Market Analysis by End User, 2017-2026
  • Figure 52: Latin America Humanized Mice Model Market Analysis by Country, 2017-2026
  • Figure 53: Europe Humanized Mice Model Market BPS Analysis, by Country, 2017 & 2025
  • Figure 54: Europe Humanized Mice Model Y-o-Y Growth Rate (%), by Country, 2016-2026
  • Figure 55: Germany Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 56: U.K. Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
  • Figure 57: France Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 58: Italy Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
  • Figure 59: Spain Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 60: Russia Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 61: Rest of Europe Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 62: Europe Humanized Mice Model Market Analysis by Model Type, 2017-2026
  • Figure 63: Europe Humanized Mice Model Market Analysis by Application, 2017-2026
  • Figure 64: Europe Humanized Mice Model Market Analysis by End User, 2017-2026
  • Figure 65: Europe Humanized Mice Model Market Analysis by Country, 2017-2026
  • Figure 66: Asia Pacific Humanized Mice Model Market BPS Analysis, by Country, 2017 & 2025
  • Figure 67: Asia Pacific Humanized Mice Model Y-o-Y Growth Rate (%), by Country, 2016-2026
  • Figure 68: China Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 69: Japan Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
  • Figure 70: India Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 71: ASEAN Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
  • Figure 72: Australia & New Zealand Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 73: Rest of APAC Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 74: Asia Pacific Humanized Mice Model Market Analysis by Model Type, 2017-2026
  • Figure 75: Asia Pacific Humanized Mice Model Market Analysis by Application, 2017-2026
  • Figure 76: Asia Pacific Humanized Mice Model Market Analysis by End User, 2017-2026
  • Figure 77: Asia Pacific Humanized Mice Model Market Analysis by Country, 2017-2026
  • Figure 78: MEA Humanized Mice Model Market BPS Analysis, by Country, 2017 & 2025
  • Figure 79: MEA Humanized Mice Model Y-o-Y Growth Rate (%), by Country, 2016-2026
  • Figure 80: GCC Countries Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 81: South Africa Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 82: Rest of MEA Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2013-2026
  • Figure 83: MEA Humanized Mice Model Market Analysis by Model Type, 2017-2026
  • Figure 84: MEA Humanized Mice Model Market Analysis by Application, 2017-2026
  • Figure 85: MEA Humanized Mice Model Market Analysis by End User, 2017-2026
  • Figure 86: MEA Humanized Mice Model Market Analysis by Country, 2017-2026
目次

Outlook of the humanized mice model market with reference to the healthcare life sciences sector

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

  • Parent Indicators Healthcare
  • Current expenditure on health, % of gross domestic product
  • Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
  • Annual growth rate of current expenditure on health, per capita, in real terms
  • Out-of-pocket expenditure, % of current expenditure on health
  • Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
  • Physicians, Density per 1000 population (head counts)
  • Nurses, Density per 1000 population (head counts)
  • Total hospital beds, per 1000 population
  • Curative (acute) care beds, per 1000 population
  • Medical technology, Magnetic Resonance Imaging units, total, per million population
  • Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

PMR utilizes a triangulation methodology that is primarily based on overall expenditure on life science research and R&D funding and capital equipment installed base to obtain precise market estimations and insights on life science and biotechnology associated products, technologies, applications and services. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country-specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product and service offerings, equipment installed base in end use facilities, adoption rate and future impact of new technologies. Additionally, per capita consumption of kits, reagents and consumables among end users is tracked at a granular level to obtain the most accurate information. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side respondents such as laboratory managers, procurement managers, research supervisors at academic and research institutes, as well as key opinion leaders in addition to supply-side respondents such as equipment and reagent manufacturers, custom solution and service providers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project year-on-year growth rates. These Y-o-Y growth projections are checked and aligned as per associated industry/product lifecycles and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse annual reports of various companies, investor presentations, SEC filings, 10k reports and earning call transcripts operating in the market to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at tier-level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as overall life science research expenditure, R&D funding, industry based demand driving factors impacting the market and its forecast trends apart from other macroeconomic factors.

  • Standard Report Structure
  • Executive Summary
  • Market Definition
  • Macro-economic analysis
  • Parent Market Analysis
  • Market Overview
  • Forecast Factors
  • Segmental Analysis and Forecast
  • Regional Analysis
  • Competition Analysis
  • Target Audience
  • Production Companies
  • Suppliers
  • Channel Partners
  • Marketing Authorities
  • Subject Matter Experts
  • Research Institutions
  • Financial Institutions
  • Market Consultants
  • Government Authorities
  • Market Taxonomy
  • The global humanized mice model has been segmented into:
  • Model Type
  • Genetic Humanized Mice Model
  • Cell-Based Humanized Mice Model
  • CD-34
  • PBMC
  • End User
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic & Research Institutes
  • Application
  • Toxicology
  • Oncology
  • Infectious Diseases
  • GvHD
  • Regenerative Medicine
  • Neurobiology
  • Others
  • Region
  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Table of Contents

1. Global Humanized Mouse Model Market - Executive Summary

2. Research Methodology

3. Assumptions and Acronyms Used

4. Global Humanized Mouse Model Market Overview

  • 4.1. Introduction
    • 4.1.1. Humanized Mouse Model Market Taxonomy
    • 4.1.2. Humanized Mouse Model Market Definition
  • 4.2. Global Humanized Mouse Model Market Dynamics
    • 4.2.1. Macro-economic Factors
    • 4.2.2. Drivers
    • 4.2.3. Restraints
    • 4.2.4. Opportunities
    • 4.2.5. Market Trends
  • 4.3. Drivers and Restraints: Impact Analysis
  • 4.4. Global Humanized Mouse Model Market Size and Forecast
    • 4.4.1. Global Humanized Mouse Model Market Y-o-Y Growth
    • 4.4.2. Global Humanized Mouse Model Market Absolute $ Opportunity

5. Global Humanized Mouse Model Market Analysis and Forecast, By Model Type

  • 5.1. Introduction
    • 5.1.1. Market Share Analysis By Model Type
    • 5.1.2. Y-o-Y Growth Projections By Model Type
  • 5.2. Market Size (US$ Mn) Forecast By Model Type
    • 5.2.1. Genetic Humanized Mice Model
    • 5.2.2. Cell-Based Humanized Mice Model
      • 5.2.2.1. CD-34
      • 5.2.2.1. PBMC
  • 5.3. Market Attractiveness Analysis By Model Type

6. Global Humanized Mouse Model Market Analysis and Forecast, By Application

  • 6.1. Introduction
    • 6.1.1. Market Share Analysis By Application
    • 6.1.2. Y-o-Y Growth Projections By Application
  • 6.2. Market Size (US$ Mn) Forecast By Application
    • 6.2.1. Toxicology
    • 6.2.2. Oncology
    • 6.2.3. Infectious Disease
    • 6.2.4. GvHD
    • 6.2.5. Regenerative Medicine
    • 6.2.6. Neurobiology
    • 6.2.7. Others
  • 6.3. Market Attractiveness Analysis By Application

7. Global Humanized Mouse Model Market Analysis Forecast, By End User

  • 7.1. Introduction
    • 7.1.1. Market Share Analysis By End User
    • 7.1.2. Y-o-Y Growth Projections By End User
  • 7.2. Market Size (US$ Mn) and Forecast By End User
    • 7.2.1. Pharmaceuticals & Biotechnology Companies
    • 7.2.2. Contract Research Organizations (CROs)
    • 7.2.3. Academic & Research Institutions
  • 7.3. Market Attractiveness Analysis By End User

8. Global Humanized Mouse Model Market Analysis and Forecast, By Region

  • 8.1. Introduction
    • 8.1.1. Market Share Analysis By Region
    • 8.1.2. Y-o-Y Growth Projections By Region
  • 8.2. Market Size (US$ Mn) and Forecast By Region
    • 8.2.1. North America
    • 8.2.2. Latin America
    • 8.2.3. Europe
    • 8.2.4. Asia Pacific
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis By Region

9. North America Humanized Mouse Model Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Market Share Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
  • 9.2. Market Size (US$ Mn) Forecast By Country
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Market Size (US$ Mn) Forecast By Model Type
    • 9.3.1. Genetic Humanized Mice Model
    • 9.3.2. Cell-Based Humanized Mice Model
      • 9.3.2.1. CD-34
      • 9.3.2.2. PBMC
  • 9.4. Market Size (US$ Mn) Forecast By Application
    • 9.4.1. Toxicology
    • 9.4.2. Oncology
    • 9.4.3. Infectious Disease
    • 9.4.4. GvHD
    • 9.4.5. Regenerative Medicine
    • 9.4.6. Neurobiology
    • 9.4.7. Others
  • 9.5. Market Size (US$ Mn) and Forecast By End User
    • 9.5.1. Pharmaceuticals & Biotechnology Companies
    • 9.5.2. Contract Research Organizations (CROs)
    • 9.5.3. Academic & Research Institutions
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Country
    • 9.6.2. By Product Type
    • 9.6.3. By Application
    • 9.6.4. By End User

10. Latin America Humanized Mouse Model Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Market Share Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
  • 10.2. Market Size (US$ Mn) and Forecast By Country
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Market Size (US$ Mn) Forecast By Model Type
    • 10.3.1. Genetic Humanized Mice Model
    • 10.3.2. Cell-Based Humanized Mice Model
      • 10.3.2.1. CD-34
      • 10.3.2.2. PBMC
  • 6.2. Market Size (US$ Mn) Forecast By Application
    • 10.4.1. Toxicology
    • 10.4.2. Oncology
    • 10.4.3. Infectious Disease
    • 10.4.7. Others
    • 10.4.5. Regenerative Medicine
    • 10.4.6. Neurobiology
    • 10.4.7. Others
  • 10.5. Market Size (US$ Mn) and Forecast By End User
    • 10.5.1. Pharmaceuticals & Biotechnology Companies
    • 10.5.2. Contract Research Organizations (CROs)
    • 10.5.3. Academic & Research Institutions
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Country
    • 10.6.2. By Product Type
    • 10.6.3. By Application
    • 10.6.4. By End User

11. Europe Humanized Mouse Model Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Market Share Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
  • 11.2. Market Size (US$ Mn) and Forecast By Country
    • 11.2.1. Germany
    • 11.2.2. France
    • 11.2.3. U.K.
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Market Size (US$ Mn) Forecast By Model Type
    • 11.3.1. Genetic Humanized Mice Model
    • 11.3.2. Cell-Based Humanized Mice Model
      • 11.3.2.1. CD-34
      • 11.3.2.2. PBMC
  • 11.4. Market Size (US$ Mn) Forecast By Application
    • 11.4.1. Toxicology
    • 11.4.2. Oncology
    • 11.4.3. Infectious Disease
    • 11.4.4. GvHD
    • 11.4.5. Regenerative Medicine
    • 11.4.6. Neurobiology
    • 11.4.7. Others
  • 11.5. Market Size (US$ Mn) and Forecast By End User
    • 11.5.1. Pharmaceuticals & Biotechnology Companies
    • 11.5.2. Contract Research Organizations (CROs)
    • 11.5.3. Academic & Research Institutions
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Country
    • 11.6.2. By Product Type
    • 11.6.3. By Application
    • 11.6.4. By End User

12. Asia Pacific Humanized Mouse Model Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Market Share Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
  • 12.2. Market Size (US$ Mn) and Forecast By Country
    • 12.2.1. China
    • 12.2.2. India
    • 12.2.3. Japan
    • 12.2.4. ASEAN
    • 12.2.5. Australia & New Zealand
    • 12.2.6. Rest of Asia Pacific
  • 12.2. Market Size (US$ Mn) Forecast By Model Type
    • 12.2.1. Genetic Humanized Mice Model
    • 12.2.2. Cell-Based Humanized Mice Model
      • 12.2.2.1. CD-34
      • 12.2.2.2 PBMC
  • 12.3. Market Size (US$ Mn) Forecast By Application
    • 12.3.1. Toxicology
    • 12.3.2. Oncology
    • 12.3.3. Infectious Disease
    • 12.3.4. GvHD
    • 12.3.5. Regenerative Medicine
    • 12.3.6. Neurobiology
    • 12.3.7. Others
  • 12.5. Market Size (US$ Mn) and Forecast By End User
    • 12.5.1. Pharmaceuticals & Biotechnology Companies
    • 12.5.2. Contract Research Organizations (CROs)
    • 12.5.3. Academic & Research Institutions
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Country
    • 12.6.2. By Product Type
    • 12.6.3. By Application
    • 12.6.4. By End User

13. MEA Humanized Mouse Model Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Market Share Analysis By Country
    • 13.1.2. Y-o-Y Growth Projections By Country
  • 13.2. Market Size (US$ Mn) and Forecast By Country
    • 13.2.1. GGC Countries
    • 13.2.2. South Africa
    • 13.2.3. Rest of MEA
  • 13.2. Market Size (US$ Mn) Forecast By Model Type
    • 13.2.1. Genetic Humanized Mice Model
    • 13.2.2. Cell-Based Humanized Mice Model
      • 13.2.2.1. CD-34
      • 13.2.2.2. PBMC
  • 13.4. Market Size (US$ Mn) Forecast By Application
    • 13.4.6. Toxicology
    • 13.4.2. Oncology
    • 13.4.3. Infectious Disease
    • 13.4.4. GvHD
    • 13.4.5. Regenerative Medicine
    • 13.4.6. Neurobiology
    • 13.4.7. Others
  • 13.5. Market Size (US$ Mn) and Forecast By End User
    • 13.5.1. Pharmaceuticals & Biotechnology Companies
    • 13.5.2. Contract Research Organizations (CROs)
    • 13.5.3. Academic & Research Institutions
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Country
    • 13.6.2. By Product Type
    • 13.6.3. By Application
    • 13.6.4. By End User

14. Competitive Landscape (Revenue, Product Offerings, Highlights)

  • 14.1. THE JACKSON LABORATORY
  • 14.2. Taconic Biosciences, Inc.
  • 14.3. Genoway S.A.
  • 14.4. Yecuris Corporation
  • 14.5. Charles River Laboratories, Inc.
  • 14.6. Crown Bioscience Inc.
  • 14.7. Ingenious Targeting Laboratory Inc.
  • 14.8 Horizon Discovery Group plc
  • 14.9. HuMurine Technologies
  • 14.10. Trans Genic Inc., Ltd.